Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | USP2 | O75604 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.37 |
| ▸ | PDE4A | P27815 | 1/20 | 0.37 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | GBA1 | P04062 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5004355 | 0.88 | TSHR (0.45) | ALDH1A1MEN1USP2MAPTKMT2A | |
| SCHEMBL17307369 | 0.88 | ALDH1A1 (0.38) | ALDH1A1MEN1USP2MAPTKMT2A | |
| SCHEMBL5001813 | 0.86 | TSHR (0.43) | ALDH1A1MEN1USP2MAPTKMT2A | |
| SCHEMBL11302636 | 0.80 | TSHR (0.38) | TSHRCYP2C9PDE4A | |
| SCHEMBL17292411 | 0.80 | GGT1 (0.43) | TSHRCYP2C9PDE4A | |
| SCHEMBL9603268 | 0.80 | ALDH1A1 (0.37) | ALDH1A1MEN1USP2MAPTKMT2A | |
| SCHEMBL3294010 | 0.77 | SMN1; SMN2 (0.42) | ALDH1A1MEN1USP2MAPTKMT2A | |
| SCHEMBL3294007 | 0.77 | SMN1; SMN2 (0.42) | ALDH1A1MEN1USP2MAPTKMT2A | |
| SCHEMBL17292182 | 0.77 | ANPEP (0.40) | ALDH1A1TSHR | |
| SCHEMBL17307361 | 0.77 | GSR (0.36) | KMT2ATSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9290851-B2 | Specific 3-alkylamino-2-hydroxysuccinic acids and their salts as corrosion inhibitors for ferrous metals | ECOLAB USA INC. (US) | 2016-03-22 | — | — | US | disclosed |
| US-9290851-B2 | Specific 3-alkylamino-2-hydroxysuccinic acids and their salts as corrosion inhibitors for ferrous metals | ECOLAB USA INC. (US) | 2016-03-22 | — | — | US | disclosed |
| US-20150345031-A1 | SPECIFIC 3-ALKYLAMINO-2-HYDROXYSUCCINIC ACIDS AND THEIR SALTS AS CORROSION INHIBITORS FOR FERROUS METALS | Ecolab USA, Inc. (US) | 2015-12-03 | — | — | US | disclosed |
| US-20150345031-A1 | SPECIFIC 3-ALKYLAMINO-2-HYDROXYSUCCINIC ACIDS AND THEIR SALTS AS CORROSION INHIBITORS FOR FERROUS METALS | Ecolab USA, Inc. (US) | 2015-12-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150345031-A1 | SPECIFIC 3-ALKYLAMINO-2-HYDROXYSUCCINIC ACIDS AND THEIR SALTS AS CORROSION INHIBITORS FOR FERROUS METALS | HAO2, HAAO, SLC30A5 | ALDH1A1 1202/4885MEN1 4214/4885USP2 792/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.